Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:11860449rdf:typepubmed:Citationlld:pubmed
pubmed-article:11860449lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:11860449lifeskim:mentionsumls-concept:C0330390lld:lifeskim
pubmed-article:11860449lifeskim:mentionsumls-concept:C0337910lld:lifeskim
pubmed-article:11860449lifeskim:mentionsumls-concept:C0039730lld:lifeskim
pubmed-article:11860449lifeskim:mentionsumls-concept:C1521991lld:lifeskim
pubmed-article:11860449lifeskim:mentionsumls-concept:C0019024lld:lifeskim
pubmed-article:11860449lifeskim:mentionsumls-concept:C1880022lld:lifeskim
pubmed-article:11860449pubmed:issue4lld:pubmed
pubmed-article:11860449pubmed:dateCreated2002-2-25lld:pubmed
pubmed-article:11860449pubmed:abstractTextTwo cases of the Thai thalassemia patients with compound heterozygosities for (deltabeta)(0)/beta(0)-thalassemia and (deltabeta)(0)-thalassemia/hemoglobin E have been reported. The first case was a 8-yr-old boy who had the following hematologic data: Hb 6.5 g/dL, Hct 20.5%, MCV 70.4 fL, MCH 22.3 pg and MCHC 31.7 g/dL. Hemoglobin analysis revealed 1.9% hemoglobin A2 and 91.7% hemoglobin F. The second case, with Hb 13.9 g/dL, Hct 41.5%, MCV 69.5 fL, MCH 22.5 pg and MCHC 32.2 g/dL, was a 16-yr-old male who had 46.1% hemoglobin E and 49.8% hemoglobin F. Globin gene analyses showed that both probands carried the same deletional type (deltabeta)(0)-thalassemia trans to the 4 bp deletions in codons 41/42 beta(0)-thalassemia and to the betaE-globin gene, respectively. Polymerase chain reaction and DNA sequence analyses demonstrated that the 5' breakpoint of the (deltabeta)(0)-thalassemia deletion was located in the second intron of the delta-globin gene and that the 3' breakpoint lay within a cluster of LI repetitive sequences at 4.7 kb 3' to the beta-globin gene.lld:pubmed
pubmed-article:11860449pubmed:languageenglld:pubmed
pubmed-article:11860449pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11860449pubmed:citationSubsetIMlld:pubmed
pubmed-article:11860449pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11860449pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11860449pubmed:statusMEDLINElld:pubmed
pubmed-article:11860449pubmed:monthOctlld:pubmed
pubmed-article:11860449pubmed:issn0902-4441lld:pubmed
pubmed-article:11860449pubmed:authorpubmed-author:FucharoenSSlld:pubmed
pubmed-article:11860449pubmed:authorpubmed-author:FucharoenGGlld:pubmed
pubmed-article:11860449pubmed:authorpubmed-author:Sanchaisuriya...lld:pubmed
pubmed-article:11860449pubmed:authorpubmed-author:SurapotSSlld:pubmed
pubmed-article:11860449pubmed:authorpubmed-author:PengjamYYlld:pubmed
pubmed-article:11860449pubmed:issnTypePrintlld:pubmed
pubmed-article:11860449pubmed:volume67lld:pubmed
pubmed-article:11860449pubmed:ownerNLMlld:pubmed
pubmed-article:11860449pubmed:authorsCompleteYlld:pubmed
pubmed-article:11860449pubmed:pagination258-62lld:pubmed
pubmed-article:11860449pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:11860449pubmed:meshHeadingpubmed-meshheading:11860449...lld:pubmed
pubmed-article:11860449pubmed:meshHeadingpubmed-meshheading:11860449...lld:pubmed
pubmed-article:11860449pubmed:meshHeadingpubmed-meshheading:11860449...lld:pubmed
pubmed-article:11860449pubmed:meshHeadingpubmed-meshheading:11860449...lld:pubmed
pubmed-article:11860449pubmed:meshHeadingpubmed-meshheading:11860449...lld:pubmed
pubmed-article:11860449pubmed:meshHeadingpubmed-meshheading:11860449...lld:pubmed
pubmed-article:11860449pubmed:meshHeadingpubmed-meshheading:11860449...lld:pubmed
pubmed-article:11860449pubmed:meshHeadingpubmed-meshheading:11860449...lld:pubmed
pubmed-article:11860449pubmed:meshHeadingpubmed-meshheading:11860449...lld:pubmed
pubmed-article:11860449pubmed:meshHeadingpubmed-meshheading:11860449...lld:pubmed
pubmed-article:11860449pubmed:meshHeadingpubmed-meshheading:11860449...lld:pubmed
pubmed-article:11860449pubmed:meshHeadingpubmed-meshheading:11860449...lld:pubmed
pubmed-article:11860449pubmed:meshHeadingpubmed-meshheading:11860449...lld:pubmed
pubmed-article:11860449pubmed:meshHeadingpubmed-meshheading:11860449...lld:pubmed
pubmed-article:11860449pubmed:meshHeadingpubmed-meshheading:11860449...lld:pubmed
pubmed-article:11860449pubmed:meshHeadingpubmed-meshheading:11860449...lld:pubmed
pubmed-article:11860449pubmed:meshHeadingpubmed-meshheading:11860449...lld:pubmed
pubmed-article:11860449pubmed:meshHeadingpubmed-meshheading:11860449...lld:pubmed
pubmed-article:11860449pubmed:year2001lld:pubmed
pubmed-article:11860449pubmed:articleTitleMolecular characterization of (deltabeta)(0)/beta(0)-thalassemia and (deltabeta)(0)-thalassemia/hemoglobin E in Thai patients.lld:pubmed
pubmed-article:11860449pubmed:affiliationDepartment of Clinical Chemistry, Faculty of Associated Medical Sciences, Khon Kaen University, Khon Kaen, Thailand. supan@mail.kku.ac.thlld:pubmed
pubmed-article:11860449pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:11860449pubmed:publicationTypeCase Reportslld:pubmed
pubmed-article:11860449pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:3043entrezgene:pubmedpubmed-article:11860449lld:entrezgene
entrez-gene:3045entrezgene:pubmedpubmed-article:11860449lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:11860449lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:11860449lld:entrezgene